tiprankstipranks

Chas McKhann Insider Profile

4 Followers
Chas McKhann, CCO at Intersect ENT, holds 0.00 shares in Intersect ENT (Ticker: XENT), holds 722.40K shares in Silk Road Medical (Ticker: SILK), holds 0.00 shares in Apollo Endosurgery (Ticker: APEN). Most recently, Chas McKhann ― shares of Intersect ENT on ― for an estimated value of ―.
tipranks
Chas McKhann

Chas McKhann
Intersect ENT (XENT)
CCO

Not Ranked
Chas McKhann has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$14M
100.00%
A breakdown of Chas McKhann's holdings

Insider Roles

Silk Road Medical
(SILK)
CEO, Director
Roles that Chas McKhann holds in companies

Most Profitable Insider Trade

Stock:
Apollo Endosurgery
(APEN)
Rating:Informative Sell
Date:Aug 20, 2021 - Aug 20, 2022
Return:+22.30%
The most profitable trade made by Chas McKhann

Chas McKhann's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
XENT
Intersect ENT
$0.00
APEN
Apollo Endosurgery
Apr 04, 2023
Uninformative Sell
$0.00
Silk Road Medical
Mar 05, 2024
CEO, Director
Uninformative Buy
$13.52M
List of latest transactions for each holding click on a transaction to see Chas McKhann's performance on stock

Chas McKhann insider profile FAQ

What is the percentage of profitable transactions made by Chas McKhann?
The percentage of profitable transactions made by Chas McKhann is ―.
    What is the average return per transaction made by Chas McKhann?
    The average return per transaction made by Chas McKhann is ―.
      What stocks does Chas McKhann hold?
      Chas McKhann holds: XENT, APEN, SILK stocks.
        What was Chas McKhann’s latest transaction?
        Chas McKhann latest transaction was an Uninformative Buy of ―.
          What was Chas McKhann's most profitable transaction?
          Chas McKhann’s most profitable transaction was an Informative Sell of APEN stock on August 20, 2021. The return on the trade was 22.30%.
            What is Chas McKhann's role in Intersect ENT?
            Chas McKhann's role in Intersect ENT is CCO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.